about
Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug usersThe law (and politics) of safe injection facilities in the United StatesSummary of findings from the evaluation of a pilot medically supervised safer injecting facilityShooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia.Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.Use of a medically supervised injection facility among street youthSelf-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark.Public crack cocaine smoking and willingness to use a supervised inhalation facility: implications for street disorder.Improving community health and safety in Canada through evidence-based policies on illegal drugs.Safer injecting facilities in Vancouver: considering issues beyond potential useA description of a peer-run supervised injection site for injection drug users.Public opinions about supervised smoking facilities for crack cocaine and other stimulantsUse of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.DETERMINANTS OF CUTANEOUS INJECTION-RELATED INFECTIONS AMONG INJECTION DRUG USERS AT AN EMERGENCY DEPARTMENT.Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico.Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime.Injection drug use cessation and use of North America's first medically supervised safer injecting facility.Increasing public support for supervised injection facilities in Ontario, Canada.IDU perspectives on the design and operation of North America's first medically supervised injection facility.Harm reduction--from a conceptual framework to practical experience: the example of Germany.Use of on-site detoxification services co-located with a supervised injection facility.Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.Employment among users of a medically supervised safer injection facility.Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture.Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility.Drug consumption rooms (DCRs) as a setting to address hepatitis C - findings from an international online surveyRecent incarceration and use of a supervised injection facility in Vancouver, CanadaCircumstances of first injection among illicit drug users accessing a medically supervised safer injection facilityFactors Associated with Public Injecting Among Users of Vancouver's Supervised Injection FacilityInjecting drug use and unstable housing: Scope for structural interventions in harm reduction
P2860
Q24561498-8E098CED-935E-4F70-9F9A-A9B842A4FC0CQ24657290-DF8B0741-37B8-4BF2-9230-0E46EC3F991DQ24673390-AC5024DB-BCBC-4407-A41D-783770AC35C5Q33271708-7E800B43-1D51-4EC4-8937-755E130017CAQ34315641-576A7CFE-CF49-4D44-B777-377DEB034961Q34403782-A18C1A6D-1093-4C7C-8FDA-3EE7038D3597Q34484766-08459720-F529-4AFC-A7A1-FF46802EE0B2Q34626103-A68ADE8B-3C00-4AA5-9141-499D37BA0217Q35896342-7B23FEE1-4EE2-42B2-98F8-A10A4B071593Q36078747-56E5218A-0AFC-491E-B371-C95A29925A2AQ36274348-FFEAB73A-59AD-42B8-8774-1CA411F62111Q36565738-B503135F-2811-4B61-91CC-7C6F44321B26Q37237728-97E4386D-3ADA-4810-BDB4-FB2CB19E4760Q37377762-07D59FEA-A611-46AB-AC23-46FFB9A9FA65Q38621000-36ECB124-6924-44BA-A540-F1FD9BC90EE0Q39756368-6EBF5940-7A80-48C8-A357-05F776D31FCAQ41502073-2450D3A9-2DD8-4A56-91C2-CC581BE20E8FQ42228767-8B35F7F9-9C91-4121-B2D2-DB7FD394D726Q42676669-6F49B00F-4EC6-4AA6-B33A-F6BD078A3BE9Q44229780-9563933A-2244-47B5-B4B3-D77FB50406D2Q45069794-76BF9790-446D-4502-A695-D4CD62F45A8AQ45130692-5833A2C8-4D64-4BF7-885D-7CFD5DBE421FQ46343537-C8A0E129-D95B-4E5F-9996-1E1773ED9437Q47316128-60A473F3-095C-4D7B-A5DF-033547187698Q52289027-E58CF18A-6727-4C14-B6BA-202449B6017EQ57132633-F5807C8F-6CE8-4787-94FE-07ABB4F97D76Q57690307-0B549592-7395-4057-8C83-0065F8AAEEF8Q57690463-929138C7-E66B-4982-9192-58EFC60836BDQ57690504-FCE48104-A212-4041-BA75-DB9852FA6D10Q57773624-5245D383-B919-46F8-9F63-55C97EA61FB4
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Drug consumption facilities: an update since 2000.
@ast
Drug consumption facilities: an update since 2000.
@en
type
label
Drug consumption facilities: an update since 2000.
@ast
Drug consumption facilities: an update since 2000.
@en
prefLabel
Drug consumption facilities: an update since 2000.
@ast
Drug consumption facilities: an update since 2000.
@en
P2093
P1476
Drug consumption facilities: an update since 2000.
@en
P2093
P304
P356
10.1080/095952301000116951
P577
2003-06-01T00:00:00Z